1. Ide A, Amino N, Kang S, Yoshioka W, Kudo T, Nishihara E, et al. Differentiation of postpartum Graves' thyrotoxicosis from postpartum destructive thyrotoxicosis using antithyrotropin receptor antibodies and thyroid blood flow. Thyroid. 2014; 24(6):1027–31.
Article
2. Momotani N, Noh J, Ishikawa N, Ito K. Relationship between silent thyroiditis and recurrent Graves' disease in the postpartum period. J Clin Endocrinol Metab. 1994; 79(1):285–9.
Article
3. Amino N, Tanizawa O, Mori H, Iwatani Y, Yamada T, Kurachi K, et al. Aggravation of thyrotoxicosis in early pregnancy and after delivery in Graves' disease. J Clin Endocrinol Metab. 1982; 55(1):108–12.
Article
4. Sartani A, Feigl D, Zaidel L, Ravid M. Painless thyroiditis followed by autoimmune disorders of the thyroid. A case report with biopsy. J Endocrinol Invest. 1980; 3(2):169–72.
Article
5. Sarlis NJ, Brucker-Davis F, Swift JP, Tahara K, Kohn LD. Graves' disease following thyrotoxic painless thyroiditis. Analysis of antibody activities against the thyrotropin receptor in two cases. Thyroid. 1997; 7(6):829–36.
Article
6. Shorey S, Badenhoop K, Walfish PG. Graves' hyperthyroidism after postpartum thyroiditis. Thyroid. 1998; 8(12):1117–22.
Article
7. Papi G, Corrado S, Carapezzi C, Corsello SM. Postpartum thyroiditis presenting as a cold nodule and evolving to Graves' disease. Int J Clin Pract. 2003; 57(6):556–8.
8. Yang JH, Han EJ, Yim CH. Two cases of postpartum thyroiditis followed by Graves' disease. J Korean Thyroid Assoc. 2013; 6(1):75–9.
Article
9. Sergi M, Tomlinson G, Feig DS. Changes suggestive of postpartum thyroiditis in women with established hypothyroidism: incidence and predictors. Clin Endocrinol (Oxf). 2014. [Epub ahead of print].
Article
10. Amino N, Mori H, Iwatani Y, Tanizawa O, Kawashima M, Tsuge I, et al. High prevalence of transient postpartum thyrotoxicosis and hypothyroidism. N Engl J Med. 1982; 306(14):849–52.
Article
11. Codaccioni JL, Orgiazzi J, Blanc P, Pugeat M, Roulier R, Carayon P. Lasting remissions in patients treated for Graves' hyperthyroidism with propranolol alone: a pattern of spontaneous evolution of the disease. J Clin Endocrinol Metab. 1988; 67(4):656–62.
Article
12. Nagai Y, Toya T, Fukuoka K, Tanaka N, Yanagi S, Kobayashi K. Occurrence and spontaneous remission of Graves' hyperthyroidism preceded by painless thyroiditis. Endocr J. 1997; 44(6):881–5.
Article
13. Noh J, Yoshimoto M, Inhikawa N, Momotani N, Hanada N, Morii H, et al. Occurrence of Graves' hyperthyroidism preceded by silent thyroiditis. Nagataki S, Torizuka K, editors. editors.The thyroid 1988. Amsterdam: Elsevier Science Publishers B.V. (Biochemical Devision);1988. p. 249–52.
14. Stagnaro-Green A, Abalovich M, Alexander E, Azizi F, Mestman J, Negro R, et al. Guidelines of the American Thyroid Association for the diagnosis and management of thyroid disease during pregnancy and postpartum. Thyroid. 2011; 21(10):): 1081–125.
Article
15. Vos XG, Smit N, Endert E, Tijssen JG, Wiersinga WM. Frequency and characteristics of TBII-seronegative patients in a population with untreated Graves' hyperthyroidism: a prospective study. Clin Endocrinol (Oxf). 2008; 69(2):311–7.
Article
16. Tamaki H, Amino N, Aozasa M, Mori M, Tanizawa O, Miyai K. Serial changes in thyroid-stimulating antibody and thyrotropin binding inhibitor immunoglobulin at the time of postpartum occurrence of thyrotoxicosis in Graves' disease. J Clin Endocrinol Metab. 1987; 65(2):324–30.
Article
17. Yabu Y, Amino N, Mori H, Miyai K, Tanizawa O, Takai SI, et al. Postpartum recurrence of hyperthyroidism and changes of thyroid-stimulating immunoglobulins in Graves' disease. J Clin Endocrinol Metab. 1980; 51(6):1454–8.
Article
18. Ikekubo K, Hino M, Ito H, Koh T, Ishihara T, Kurahachi H, et al. Thyrotoxic Graves' disease with normal thyroidal technetium-99m pertechnetate uptake. Ann Nucl Med. 1990; 4(2):43–8.
Article